At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG
In Brief
A Phase 2 clinical trial evaluating Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, and 3 other interventions for Stage I Bladder Cancer and 2 related conditions. Completed, enrolled 31 participants across 6 sites.
Detailed Summary
Green tea extract contains ingredients that may slow the growth of certain cancers. It is not yet known whether green tea extract is more effective than a placebo when given before surgery in treating patients with bladder. This randomized phase II trial is studying green tea extract to see how well it works compared to a placebo when given before surgery in treating patients with nonmetastatic bladder cancer.
Study Details
Timeline
Interventions
Given orally
Correlative studies
Correlative studies
Given orally
Undergo surgery